Tag: Pneumonia
ICU for Pneumonia in Elderly Ups Survival, Not Costs
More liberal admission policies could benefit these patients, researchers say
Systemic Corticosteroid Therapy Can Improve Outcomes in CAP
Mortality, need for mechanical ventilation, hospital stay down in community-acquired pneumonia
Macrolide-Resistant M. pneumoniae in All U.S. Regions
Prevalence of 13.2 percent in sample of 91 M. pneumoniae-positive specimens from six locations
Considerable Burden for Community-Acquired Pneumonia
Incidence of community-acquired pneumonia requiring hospitalization is highest in elderly
PCV13 Predicted to Be Cost Saving Versus PCV7
Although 13-valent pneumococcal vaccine is more costly than PCV7, net cost savings expected
Community-Acquired Pneumonia Confers Long-Term Risk
High risk of long-term adverse events versus general population, irrespective of age
Macrolide Resistance Doesn’t Impact Pneumonia Outcomes
Patients hospitalized with macrolide-resistant S. pneumoniae not more severely ill at presentation
ATS: Risk of Pneumonia Up With Inhaled Corticosteroids in COPD
Observational studies show reduction in odds of pneumonia-associated, all-cause mortality
DPP-4 Inhibitors Not Tied to Pneumonia Hospitalizations
Findings among new users of antidiabetic drugs from 2007 to 2012
Outcomes No Worse for Macrolide-Resistant Pneumonia
Macrolide-resistance has no effect on outcomes as a function of compliance with current tx guidelines
